Connor, Clark & Lunn Investment Management (CC&L)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.9M Buy
158,852
+72,286
+84% +$22.7M 0.18% 107
2025
Q1
$26.4M Buy
86,566
+21,150
+32% +$6.44M 0.12% 149
2024
Q4
$21.7M Buy
65,416
+38,991
+148% +$13M 0.1% 159
2024
Q3
$8.82M Buy
26,425
+21,764
+467% +$7.26M 0.04% 312
2024
Q2
$1.92M Sell
4,661
-1,844
-28% -$759K 0.01% 666
2024
Q1
$2.63M Sell
6,505
-1,522
-19% -$615K 0.01% 602
2023
Q4
$2.46M Sell
8,027
-11,893
-60% -$3.65M 0.01% 617
2023
Q3
$4.82M Buy
19,920
+5,956
+43% +$1.44M 0.03% 408
2023
Q2
$3.35M Buy
13,964
+10,940
+362% +$2.63M 0.02% 474
2023
Q1
$569K Sell
3,024
-22,430
-88% -$4.22M ﹤0.01% 847
2022
Q4
$5.41M Sell
25,454
-8,430
-25% -$1.79M 0.03% 342
2022
Q3
$5.33M Buy
33,884
+2,115
+7% +$332K 0.03% 315
2022
Q2
$4.76M Buy
31,769
+9,688
+44% +$1.45M 0.03% 321
2022
Q1
$3.61M Sell
22,081
-3,110
-12% -$509K 0.02% 384
2021
Q4
$5.48M Buy
25,191
+3,696
+17% +$804K 0.03% 322
2021
Q3
$4.07M Buy
21,495
+12,185
+131% +$2.31M 0.02% 380
2021
Q2
$1.64M Buy
+9,310
New +$1.64M 0.01% 581
2019
Q3
Sell
-85,425
Closed -$5.59M 1038
2019
Q2
$5.59M Sell
85,425
-12,031
-12% -$787K 0.04% 262
2019
Q1
$5.75M Sell
97,456
-65,977
-40% -$3.89M 0.04% 259
2018
Q4
$8.65M Buy
163,433
+41,762
+34% +$2.21M 0.06% 203
2018
Q3
$7.29M Buy
121,671
+105,271
+642% +$6.31M 0.04% 255
2018
Q2
$705K Buy
16,400
+7,925
+94% +$341K ﹤0.01% 695
2018
Q1
$296K Buy
+8,475
New +$296K ﹤0.01% 620